Skip to main content

Table 2 Outcomes within each primary site correlated with AJCC stage

From: Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience

  No. of patients 5-yr LC p-value 5-yr LRC p-value 5-yr DFS p-value
Oral cavity        
   Stage III 2 50% 0.13 50% 0.13 50% 0.13
   Stage IV 16 8.1%   8.1%   8.1%  
Oropharynx        
   Stage III 40 68.8% 0.08 68.8% 0.01 68.8% 0.004
   Stage IV 78 53.6%   36.4%   29.5%  
Hypopharynx        
   Stage III 42 66.9% 0.16 59.3% 0.01 59.3% 0.009
   Stage IV 51 53.2%   34.4%   31.2%  
Larynx        
   Stage III 12 80.2% 0.83 80.2% 0.15 80.2% 0.07
   Stage IV 23 67.8%   34.3%   28%  
  1. LC = local control; LRC = loco-regional control; DFS = disease-free survival